A position paper on drug-pricing strategies for prescription pharmaceuticals in Canada. Canadian Cardiovascular Society.
D002170:Canada; D002309:Cardiology; D002317:Cardiovascular Agents / Q000191:economics*; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000191:economics; D003363:Cost Control; D016527:Drug Costs; D006801:Humans; D011306:Prescription Fees / Q000592:standards*; D011787:Quality of Health Care; D011907:Rate Setting and Review; D012106:Research; D012955:Societies, Medical
D002317:Cardiovascular Agents